Richa Attre

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

C. Bachert, O. Pfaar, A. Peters, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Treatment of Post-operative Inflammation following Cataract Surgery – A Review

H. Dua, Richa Attre, 2012 .

Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

L. Milani, B. Nordestgaard, K. Hveem, 2023, Critical care explorations.

Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.

M. Ardeleanu, Dateng Li, G. Geba, 2022, The Journal of allergy and clinical immunology.